Thrombosis Risk
3 COMMENTS - Jan 12, 2009 02:02 EST
NATF's vision is to improve patient care, outcomes, and public health by utilizing a multidisciplinary approach to advance thrombosis research and education. NATF's legacy will be the improvement of patient care, outcomes, and public health by supporting thrombosis-related programs, such as novel research projects, innovative educational programs, public policy initiatives, regulatory issues and advocacy. NATF also seeks to broaden training opportunities for physicians, scientists, and other health professionals.
button
Previews
Featured CME
Poll
Would you feel comfortable stopping clopidogrel for 5-10 days if a patient with a DES required surgery?
See: Shelley Wood. Five-to-10 day cessation of thienopyridine likely safe for surgery if aspirin maintained, post-DES.
Yes
No